Skip to main content

Table 4 Association between suboptimal EF at baseline and risk factors

From: Role of baseline echocardiography prior to initiation of anthracycline-based chemotherapy in breast cancer patients

Variable

Non

Yes

P value

Diabetes

  

0.3

Non

167 (83.1)

4 (66.7)

 

Yes

34 (16.9)

2 (33.3)

 

Dyslipidemia

  

0.3

No

163 (81.5)

4 (66.7)

 

Yes

37 (18.5)

2 (33.3)

 

Hypertension

  

0.2

No

149 (74.1)

3 (50.0)

 

Yes

52 (25.9)

3 (50.0)

 

aCAD

  

0.01*

No

195 (97.5)

4 (66.7)

 

Yes

5 (2.5)

2 (33.3)

 

Smoking status

  

0.1

No

124 (63.3)

5 (100.0)

 

Yes

72 (36.7)

0 (0.0)

 

bBMI

   

0 (18–25)

54 (28.0)

2 (40)

1.0

1 (25–30)

72 (37.3)

2 (40)

 

2 (30–35)

46 (23.8)

1 (20)

 

3 (35–40)

15 (7.8)

0 (0.0)

 

4 (>40)

5 (2.6)

0 (0.0)

 

5 (<18)

1 (0.5)

0 (0.0)

 
  1. *P value < 0.05 statistically significant. aCAD: Coronary artery disease. bBMI: Body Mass Index.